Article
PMPRB Consults Further On Revised Proposed Practice Directions
The Patented Medicine Prices Review Board (PMPRB) has launched a second 30-day consultation on revised proposed Practice Directions for hearings related to excessive medicine pricing and compliance with filing requirements. The revised directions incorporate feedback from the initial consultation, with a summary chart detailing all edits available for stakeholder review.
Smart & Biggar